The prevalence of HLA-B*57 serotype associated with hypersensitivity reactions in the treatment of HIV infection in the Turkish population.

Muhammed Ali Kizmaz Abdurrahman SimsekFigen AymakEmin Halis Akalın Haluk Barbaros Oral Ferah Budak

Published in: Current HIV research (2023)

Considering these results, it can be assumed that the prevalence of HLA-B*57:01 in Turkey is lower than 3.3%. Instead of a high-resolution HLA-B*57:01 scan in all patients starting abacavir therapy, a high-resolution HLA-B*57:01 scan might be of greater benefit in patients who are positive on a low-resolution HLA-B*57 scan.

Keyphrases

high resolution
end stage renal disease
computed tomography
ejection fraction
newly diagnosed
chronic kidney disease
risk factors
prognostic factors
mass spectrometry
stem cells
klebsiella pneumoniae